‹ KRYS latest research

KRYS (Krystal Biotech, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed KRYS on 10 market nights between May 5, 2026 and July 15, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

10 calls 10 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 5 of 10
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
July 15, 2026 BUY $339.43 — / — -3.8% -5.0%
Continued strong revenue growth and market adoption of VYJUVEK.
June 22, 2026 BUY $348.06 $375.88 / $313.25 +10.1% -1.3%
The 52-week breakout suggests potential for continued momentum over the coming weeks.
June 19, 2026 BUY $348.06 $405.30 / $295.85 +10.1% -1.3%
The stock is breaking out on high volume, indicating potential for sustained upward momentum.
June 18, 2026 BUY $341.66 $386.87 / $289.41 +7.0% -2.5%
The stock is approaching its 52-week high and shows strong bullish sentiment, suggesting potential for continued upward momentum.
June 12, 2026 BUY $321.55 — / — +8.0% +6.8%
The current market and stock-specific technicals do not present a clear, high-conviction entry point.
June 3, 2026 BUY $293.21 — / — +3.5% +24.3%
The current technical setup does not provide a clear entry point with favorable risk/reward.
May 12, 2026 BUY $312.88 $357.81 / $265.95 -5.5% +0.7%
The stock is breaking out to new highs, suggesting momentum could carry it higher over the coming weeks.
May 11, 2026 BUY $305.71 $349.80 / $259.13 -6.8% -1.0%
The post-earnings drift signal suggests continued upward momentum over the coming weeks.
May 6, 2026 BUY $284.57 — / — +8.2% +6.5%
Continued strong performance and market adoption of VYJUVEK.
May 5, 2026 BUY $286.95 $330.00 / $243.94 +9.1% +6.1%
The stock is consolidating near resistance, and a clear catalyst is needed for a bullish entry in this neutral market.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.